# AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

> **NCT05683379** · — · RECRUITING · sponsor: **REGENXBIO Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DIAGNOSTIC_TEST:** AAV8 DetectCDx

## Key facts

- **NCT ID:** NCT05683379
- **Lead sponsor:** REGENXBIO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-20
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05683379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05683379, "AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05683379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*